Revenue

With funding from a mining giant, Finlay Minerals' latest results identify three major drill-ready copper-gold targets in BC's Toodoggone district.

New subgroup data from ITM's COMPETE trial could refine treatment for a tough-to-treat cancer and bolster the company's position in the radiopharma market.

As teen mental health struggles soar, experts offer a new playbook for parents, blending virtual care with timeless advice on connection and support.

With legendary geologist Doug Kirwin and Latin America expert Carlos Velásquez on board, Terra Rossa is set to unlock its high-grade Vetas gold project.

With its 9th acquisition, Nexus IT expands its cybersecurity and compliance footprint, highlighting a trend of private equity-fueled consolidation in the MSP market.

At MWC 2026, First Orion unveils its expanded Global Exchange, adopting CAMARA APIs to fight spam and double its branded calling reach by year-end.

The spirits giant faces a steep sales decline and a massive write-down, pivoting to premium brands and operational fixes amid an industry-wide hangover.

In a landmark move, mitú appoints Vanessa Vigil as President. Her rise signals a new chapter for the media giant and a milestone for Latina leadership.

AI-first firms face a hidden 'tax,' taking 80 days longer and paying 135% more to recover from cyberattacks, a new report from Fastly reveals.

Strategic Resources navigates a key environmental review for its iron ore pellet plant, tapping into Quebec's hydro power for the global green steel market.

As Evolus presents at a key healthcare conference, investors watch to see if its new filler line and digital strategy can deliver on bold promises.

After a breakout first year, Maine's sustainable canned water brand is expanding into Boston and Florida, leveraging its pure origins and a veteran sales team.

Intellicheck's new desktop tool promises immediate, advanced identity verification without complex integration, leveling the security field for businesses.

Investors sue Corcept Therapeutics, claiming the company hid FDA warnings about its key drug, relacorilant, before a 50% stock price collapse.

P4ML joins the Orphan Therapeutics Accelerator to bring shelved cures to patients, leveraging a new non-profit model and expanding access to the MENA region.

The cybersecurity firm will provide quantum-resistant tech for a massive MDA program, aiming to secure critical U.S. systems against future cyber threats.

New research shows assessment fraud more than doubled in 2025, driven by AI and hitting entry-level roles hardest. How can companies ensure fair hiring?

As AI adoption stalls at the pilot stage, new labs in Singapore, Japan, and the UK offer a crucial sandbox for testing high-stakes hybrid cloud deployments.

Legal tech firm DISCO reports strong growth fueled by a 600% surge in AI revenue, launching agentic AI and a disruptive new all-in-one pricing model.

With a key gene therapy approval imminent and major clinical data on deck, REGENXBIO's upcoming financial report will be a crucial test for the biotech.